Fotemustine‐based therapy in combination with rituximab as first‐line induction chemotherapy followed by wbrt for newly diagnosed pcnsl: a prospective phase ii trial
Hematological Oncology(2021)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Hematological Oncology(2021)